Home › Bloedkankers › Illinois › Chicago
Bloedkankers klinische studies in Chicago, IL
15 studies voor Bloedkankers zoeken deelnemers op locaties in en rond Chicago (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruterenObservatieonderzoek
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RekruterenFase 3
- The University of Chicago ( Site 0020), Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- en nog 1
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruterenFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Tempus AI, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Rekruteren
- Northwestern University Feinberg School of Medicine, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- en nog 2
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RekruterenFase 3
- Northwestern University, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruterenFase 1
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruterenFase 1/2
- Northwestern Memorial Hospital, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruterenFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Rekruteren
- University of Chicago Comprehensive Cancer Center, Chicago
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
RekruterenFase 1
- Northwestern University - Feinberg School of Medicine, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
RekruterenObservatieonderzoek
- MPN Research Foundation, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruterenFase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Bloedkankers studies in andere steden
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Seattle, WA18 studies
- Baltimore, MD18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Philadelphia, PA14 studies
- Columbus, OH13 studies
- Edison, NJ13 studies
- Nashville, TN13 studies
Andere studies in Chicago
- Niet-kleincellige longkanker61 studies
- Borstkanker59 studies
- Kanker (alle vormen)51 studies
- Metastatische kanker45 studies
- Prostaatkanker45 studies
- Longkanker41 studies
- Obesitas41 studies
- Eierstokkanker36 studies
- Colorectale kanker34 studies
- Beroerte34 studies
- Hartfalen31 studies
- Overgewicht29 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.